Spots Global Cancer Trial Database for salivary gland adenoid cystic carcinoma
Every month we try and update this database with for salivary gland adenoid cystic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma | NCT01604772 | Recurrent Oral ... Recurrent Saliv... Salivary Gland ... Stage IVA Major... Stage IVA Oral ... Stage IVB Major... Stage IVB Oral ... Stage IVC Major... Stage IVC Oral ... | Akt Inhibitor M... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Imatinib Mesylate in Treating Patients With Salivary Gland Cancer | NCT00045669 | Head and Neck C... | imatinib mesyla... | 18 Years - 120 Years | University Health Network, Toronto | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | NCT00017498 | Head and Neck C... | gemcitabine hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma | NCT01175980 | Recurrent Oral ... Recurrent Saliv... Salivary Gland ... Stage III Major... Stage III Oral ... Stage IVA Major... Stage IVA Oral ... Stage IVB Major... Stage IVB Oral ... Stage IVC Major... Stage IVC Oral ... Tongue Carcinom... | Laboratory Biom... Vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors | NCT00859937 | Malignant Saliv... Recurrent Saliv... Salivary Gland ... Stage IV Major ... | Dasatinib Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | NCT00003744 | Head and Neck C... | gemcitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck | NCT00077428 | Recurrent Adeno... Recurrent Saliv... Salivary Gland ... Stage III Adeno... Stage III Saliv... Stage IV Adenoi... Stage IV Saliva... | bortezomib doxorubicin hyd... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Imatinib Mesylate in Treating Patients With Salivary Gland Cancer | NCT00045669 | Head and Neck C... | imatinib mesyla... | 18 Years - 120 Years | University Health Network, Toronto | |
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma | NCT01175980 | Recurrent Oral ... Recurrent Saliv... Salivary Gland ... Stage III Major... Stage III Oral ... Stage IVA Major... Stage IVA Oral ... Stage IVB Major... Stage IVB Oral ... Stage IVC Major... Stage IVC Oral ... Tongue Carcinom... | Laboratory Biom... Vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | NCT00003744 | Head and Neck C... | gemcitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | NCT00851253 | Head and Neck C... | stereotactic ra... | 18 Years - | Boston Medical Center | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | NCT00017498 | Head and Neck C... | gemcitabine hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma | NCT01604772 | Recurrent Oral ... Recurrent Saliv... Salivary Gland ... Stage IVA Major... Stage IVA Oral ... Stage IVB Major... Stage IVB Oral ... Stage IVC Major... Stage IVC Oral ... | Akt Inhibitor M... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor | NCT00079079 | Head and Neck C... | carboplatin cisplatin gemcitabine hyd... | 18 Years - 120 Years | Canadian Cancer Trials Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
